Standard of care
Adaptive radiotherapy
In-room imaging
Prostate
Pancreas
Brain tumors
Breast cancer
Gynecological
Head & neck cancer
Kidney cancer
Close
Products
Radiation Therapy
Treatment Delivery
Elekta Unity
Elekta Versa HD®
Elekta Harmony
Elekta Infinity
Quality Assurance
Stereotactic Radiosurgery
Delivery
Elekta Esprit
Versa HD
Treatment Planning
Leksell GammaPlan
Oncology Software
Elekta ONE
Oncology care
Smart Workflows
Treatment Applications
Real-world outcomes
Subscribe to Better
Elekta Axis Cloud
Interoperability
Professional Services
Brachytherapy
Delivery
Elekta Studio
ImagingRing
Oncentra Brachy
Venezia
Flexitron
Geneva
Xoft
Body Sites
Head and Neck
Bronchus and Oesophagus
Breast
Skin
Prostate
Rectal
Bladder
Cervix
Neurosurgery
Delivery
Leksell Vantage Stereotactic System
Veterinary Radiation Therapy
Close
Services
Elekta Care
Elekta Care Support Services
Elekta Care 360
Elekta Care Learning
Elekta Care Community
Elekta Partner Community
Close
Patients
MR-Linac Treatment
Brachytherapy Treatment
Gamma Knife Treatment
Radiation Therapy Treatment
Treatment Centers
Close
Company
Company
Partnering with Elekta
About us
About us
Board of Directors
Code of Conduct
Corporate Citizenship
Executive Committee
Integrity Line
Programs
Risk management
Story
Sustainability
Corporate Governance
Corporate Governance
Shareholders’ meetings
Board of Directors
Executive Committee
Auditors
Reports
Investors
Investors
Outlook
The share
Financials
Funding
Reports & presentations
Press releases
Newsroom
IR calendar
IR contacts
Newsroom
Newsroom
Press Releases
FOCUS Magazine
Videos
Image bank
Careers at Elekta
Jobs
Close
EN
SV
Login
Products
Radiation Therapy
Treatment Delivery
Elekta Unity
Elekta Versa HD®
Elekta Harmony
Elekta Infinity
Quality Assurance
Stereotactic Radiosurgery
Delivery
Elekta Esprit
Treatment Planning
Leksell GammaPlan
Versa HD
Oncology Software
Elekta ONE
Oncology care
Smart Workflows
Treatment Applications
Real-world outcomes
Subscribe to Better
Elekta Axis Cloud
Interoperability
Professional Services
Brachytherapy
Elekta Studio
ImagingRing
Venezia
Flexitron
Geneva
Head and Neck
Bronchus and Oesophagus
Xoft
Breast
Skin
Prostate
Rectal
Bladder
Cervix
Oncentra Brachy
Neurosurgery
Leksell Vantage Stereotactic System
Veterinary Radiation Therapy
Services
Elekta Care
Elekta Care Support Services
Elekta Care 360
Elekta Care Learning
Elekta Care Community
Elekta Partner Community
Patients
MR-Linac Treatment
Brachytherapy Treatment
Gamma Knife Treatment
Radiation Therapy Treatment
Treatment Centers
Company
Partnering with Elekta
About us
Board of Directors
Code of Conduct
Corporate Citizenship
Executive Committee
Integrity Line
Programs
Risk management
Story
Sustainability
Corporate Governance
Shareholders’ meetings
Board of Directors
Executive Committee
Auditors
Reports
Investors
Outlook
The share
Financials
Funding
Reports & presentations
Press releases
Newsroom
IR calendar
IR contacts
Newsroom
Press Releases
FOCUS Magazine
Videos
Image bank
Careers at Elekta
Jobs
Contact
Medical Affairs
Regulatory Affairs
Suppliers
About Elekta Procurement
Sustainable Sourcing
Performance Management
Production Part Approval Process
Supplier Escalation Form
Non Conformance Management
Supplier Performance Management
Obsolescence Management
Compliance Management
Invoicing Process
Elekta T&C
Documents & Training
Our Global Presence
Standard of care
Adaptive radiotherapy
In-room imaging
Prostate
Pancreas
Brain tumors
Breast cancer
Gynecological
Head & neck cancer
Kidney cancer
Press releases
Subscribe
Investors
Outlook
The share
Financials
Funding
Reports & presentations
Press releases
Newsroom
IR calendar
IR contacts
Search
Type
All releases
Regulatory
Non regulatory
Year
All years
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
September 29, 2026
New phase 2 data show favorable cognitive outcomes with Leksell Gamma Knife in patients with up to 50 brain metastases
September 28, 2026
Study presented at ASTRO shows promising long-term outcomes for patients with localized pancreatic cancer treated on Elekta Unity
September 27, 2026
Elekta expands adaptive workflows across its radiotherapy portfolio
September 3, 2026
Regulatory
Report from the Annual General Meeting 2026 of Elekta
August 27, 2026
Regulatory
First quarter, May–July 2026/27
August 13, 2026
Invitation to the presentation of Elekta’s first quarter 2026/27
July 31, 2026
Regulatory
Notice to the Annual General Meeting of Elekta AB (Publ)
July 3, 2026
Regulatory
Elekta's Annual Report for 2025/26 available
June 17, 2026
Regulatory
Elekta presents financial targets and detailed outlook ahead of Capital Markets Day
June 12, 2026
Nomination Committee’s proposal for the Board of Directors prior to Elekta’s Annual General Meeting 2026
May 28, 2026
Regulatory
Year-end report May–April 2025/26
May 18, 2026
New research presented at ESTRO 2026 highlights advances in MR-guided radiotherapy
May 13, 2026
Invitation to the presentation of Elekta’s fiscal year 2025/26
April 17, 2026
Invitation to Elekta's Capital Markets Day on June 17, 2026
March 5, 2026
Regulatory
Third quarter, November–January 2025/26
February 25, 2026
Regulatory
Change in Elekta’s Nomination Committee for the Annual General Meeting 2026
February 19, 2026
Invitation to Elekta’s Q3 2025/26 call at 9:00 a.m. CET, March 5
January 30, 2026
Elekta presents Strategic Update: growth, innovation, and operations
January 23, 2026
Elekta appoints Tomas Eliasson as Vice Chair of the Board
January 16, 2026
Regulatory
Elekta receives FDA 510(k) clearance for Elekta Evo linear accelerator
January 12, 2026
Invitation to Elekta's Strategic Update event on January 30
Subscribe to press releases